Table 4.
Independent risk factors in ART regimens for liver steatosis in Chinese AIDS patients with hypertriglyceridemia analyzed with multivariate logistic regression analysis
| |
|
|
|
|
|
Mutivariate analysis |
|
|---|---|---|---|---|---|---|---|
| HIV medications | All patients | Non-steatosis | Steatosis | χ2 | P value | OR | P value |
| AZT |
73 (44.8%) |
32 (36.4%) |
41 (54.7%) |
11.07 |
0.011 |
2.11 |
0.001 |
| d4T |
66 (40.5%) |
39 (44.3%) |
27 (36.0%) |
|
|
3.75 |
0.01 |
| EFV |
55 (33.7%) |
19 (21.6%) |
36 (48.0%) |
|
|
3.35 |
0.07 |
| NVP |
78 (47.9%) |
52 (58.0%) |
37 (36.0%) |
|
|
0.41 |
0.0003 |
| Others | 17 (9.8%) | 9 (10.2%) | 8 (9.3%) | 0.90 | 0.36 | ||
Notes: AZT Zidovudine, d4T Stavudine, EFV Efavirenz, NVP Nevirapine.